Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multidrug resistance.

M I Tiirikainen1, T Krusius

  • 1Finnish Red Cross, Blood Transfusion Service, Helsinki.

Annals of Medicine
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Malignant cells develop multidrug resistance (MDR) via P-glycoprotein, a pump that reduces drug accumulation. Understanding and reversing this P-glycoprotein function is key to improving chemotherapy effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Red blood cell transfusion in southern Finland from 2011 to 2016: a quality audit.

Transfusion medicine (Oxford, England)·2018
Same author

Evaluation of soluble glycoprotein V as an in vitro quality marker for platelet concentrates: a correlation study between in vitro platelet quality markers and the effect of storage medium.

Vox sanguinis·2016
Same author

The Use of Blood Products in Adult Patients with Burns.

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society·2016
Same author

Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of care.

Vox sanguinis·2014
Same author

Measures to prevent transfusion-related acute lung injury (TRALI).

Vox sanguinis·2012
Same author

Prion reduction of red-blood-cells.

Vox sanguinis·2012

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Malignant cell resistance to chemotherapy limits treatment success.
  • Multidrug resistance (MDR) is often mediated by P-glycoprotein (P-gp) overexpression.
  • P-gp acts as an efflux pump, reducing intracellular cytotoxic drug concentrations.

Purpose of the Study:

  • To explore the role of P-glycoprotein in multidrug resistance.
  • To investigate the correlation between P-glycoprotein expression and clinical drug resistance.
  • To identify strategies for preventing P-gp function and reversing drug resistance.

Main Methods:

  • Analysis of P-glycoprotein expression in malignant cells.
  • Correlation studies between P-gp levels and patient response to chemotherapy.

Related Experiment Videos

  • Investigation of potential mechanisms to inhibit P-gp activity.

    • Main Results:

    • P-glycoprotein overexpression is linked to simultaneous resistance to multiple unrelated drugs.
    • P-gp is present in normal tissues, potentially contributing to intrinsic resistance.
    • Acquired multidrug resistance during chemotherapy is frequently associated with P-gp.

    Conclusions:

    • P-glycoprotein is a significant factor in both intrinsic and acquired multidrug resistance.
    • Targeting P-glycoprotein offers a potential strategy to overcome chemotherapy resistance.
    • Further research is needed to elucidate P-gp's physiological role and therapeutic inhibition.